SCOTT MUELLER: Open Payments
NPI 1821034158 · NEW CUMBERLAND, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 98 payments from 13 companies in 2025. Trend: 2023 $3,694 · 2024 $2,924 · 2025 $1,835
Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $383 |
| ABBVIE INC. | 16 | $359 |
| Lilly USA, LLC | 16 | $312 |
| PFIZER INC. | 13 | $188 |
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| Amgen Inc. | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Merck Sharp & Dohme LLC | 2 | $52 |
Products named: JARDIANCE, Wegovy, QULIPTA, UBRELVY, MOUNJARO, AIRSUPRA, ELIQUIS, Rybelsus.
Industry payments across PA — which companies pay providers there.
